Metagenomi Therapeutics, Inc. (MGX) › Shares OutstandingMetagenomi Therapeutics, Inc. (MGX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2023: 3.40M2024: 37.42M2025: 37.62M37.62M2023Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202537.62M+0.5%202437.42M+999.1%20233.40M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share